Ethics approval has been submitted. That was acknowledged by David in the very recent investor update.
They were expecting a reply around Christmas. I'd posit that while it's still very early January and there are breaks over Christmas and new year, timing is fair.
If biotech were analogous to a mining operation, then the concern with "deadlines" would be apt. But it's not. It's an evolving scientific beast. One which we've continued to throw expertise towards with new hires and a massive funding program.
I'd posit that most long term holders understand this reality.
General Comments / Chat, page-4828
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.42 |
Change
-0.020(1.39%) |
Mkt cap ! $241.2M | |||
| Open | High | Low | Value | Volume |
| $1.42 | $1.42 | $1.41 | $11.52K | 8.176K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6544 | $1.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 2460 | 2 |
View Market Depth
| Last trade - 10.42am 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.46 |
Change
-0.020 ( 0.65 %) |
||||
| Open | High | Low | Volume | ||
| $1.41 | $1.46 | $1.41 | 2910 | ||
| Last updated 10.54am 31/05/2024 ? | |||||
| RAC (ASX) Chart |